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Abstract
Heparin-induced thrombocytopenia (HIT) is one of the most common immune-mediated adverse drug reactions,
with frequencies as high as 2-3% for certain groups of post-cardiac surgery patients. We report on an 50-year-old
woman with early post-operative thrombosis of the prosthetic mitral valve due to heparin-induced
thrombocytopenia. Non-invasive imaging (two-dimensional transesophageal echocardiography; 2D-TEE) allowed
the exact localisation of thrombotic masses and revealed the increase of the mean diastolic mitral gradient. The
HIT diagnosis was proved by the clinical scoring system, and with the identification of heparin platelet factor 4-
induced antibodies. After the withdrawal of LMWH therapy and the start of intravenous lepirudin treatment, the
patient’s medical condition improved continuously. Follow-up echocardiography showed a step-wise decrease in
the severity of the mean diastolic mitral valve gradient and a complete resolution of thrombus formations. Perhaps
we may remind ourselves that, whilst HIT is one of the most common immune-mediated adverse drug reactions
for certain groups of post-cardiac surgery patients, it can be managed successfully. We would also stress the
importance of serial 2D-TEE examinations in the early post-operative period.
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Background
Patients who are candidates for cardiac surgery require
special care in respect of heparin-induced thrombocyto-
penia (HIT), as this patient population exhibits a rela-
tively high risk for this antibody-mediated,
prothrombotic adverse effect of heparin. However, mon-
itoring the platelet count for HIT is a standard feature
of post-operative care in cardiac surgery. Unfractionated
heparin is remarkably immunogenic, as 25% - 50% of
post-cardiac surgery patients develop heparin-dependent
antibodies during the 5 - 10 days following surgery
[1,2]. Sometimes these antibodies strongly activate plate-
lets and coagulation, thereby causing prothrombotic dis-
order [3], with the risk of heparin-induced
thrombocytopenia at 1% - 3%.
Case presentation
A 50-year-old housewife with a history of paroxysmal
supraventricular tachycardia and rapidly worsened dys-
pnea due to serious mitral regurgitation was referred to
our hospital for the evaluation of valvular disease. The
two-dimensional transesophageal echocardiography (2D-
TEE) confirmed the diagnosis of severe MR and identi-
fied a prolapse of the P2 scallop of the posterior mitral
leaflet. Severe MR was confirmed by a vena contracta of
7 mm, the effective regurgitant orifice of 0.9 cm2, and
systolic reversal during Doppler investigation of the pul-
monary venous flow. Because of the rapid progression
of symptoms (orthopnea and threatening pulmonary
edema) the patient was referred to the Cardio-surgery
Department, where a prosthetic mitral valve was
implanted (Sorin Allcarbon 27). During the first post-
operative week the patient was on low-molecular-weight
heparin (LMWH) treatment and she was examined by
transthoracic echocardiography (TTE) every day.* Correspondence: sandor.szabados@aok.pte.hu
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On the 8th post-operative day, whilst the patient was
still on intravenous heparin, the TTE showed a consid-
erable increase of the mean diastolic mitral gradient of
8.9 mmHg. A 2D-TEE was carried out immediately; this
confirmed the increase of the mean diastolic mitral gra-
dient (9 mmHg; Figure 1) and completely revealed the
underlying mechanisms. We observed an extremely ser-
ious obstructive thrombotic mass which was attached to
and around the ring of the prosthetic mitral valve (Fig-
ure 2). Further, a 12 mm-long mobile, elongated
thrombus formation was attached to the posterior leaflet
of the prosthetic valve (marked with an arrow on Figure
3). Another spherical thrombus which was 10 mm in
diameter hampered the proper movement of the ante-
rior leaflet of the artificial valve (Figure 4). According to
the recent guidelines it is well known, that the size and
mobility of vegetations are powerful echocardiographic
predictors of new embolic events. Patients with vegeta-
tions greater than 10 mm are at higher risk of embo-
lism. This risk is even higher in patients with very large
(> 15 mm) and mobile vegetations [4].
Figure 1 Transmitral continuous-wave Doppler showing
abnormal hemodynamics of the prosthetic mitral valve. 2D-TEE
confirmed the increase of the mean diastolic mitral gradient of 9
mmHg.
Figure 2 Mid-esophageal transverse 2-chamber view showing
diffuse thrombosis of the prosthetic mitral valve leaflets
causing severe leaflet restriction and stenosis. 2D-TEE revealing
large, obstructive thrombotic masses which are attached all around
the ring of the prosthetic mitral valve, and adhering to the left atrial
wall (double white arrows).
Figure 3 2-D TEE was performed on the 8th post-operative day.
A 2D-TEE image reveals a 12 mm- long mobile, elongated
thrombus which is fixed to the posterior leaflet of the prosthetic
valve and floats along the postero-lateral wall to the left atrium
(marked with a white arrow).
Figure 4 2-D TEE was performed on the 8th post-operative day.
Another spherical thrombus, 10 mm in diameter and obstructing
the proper movement of the anterior leaflet of the prosthetic valve
(marked with white arrow).
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At the same time we observed a rapid decrease in the
platelet count from 178 G/l to 17 G/l. On the basis of
the clinical symptoms, we used the ‘4 Ts’ routine blood
chemistry pre-test clinical scoring system to test for the
possibility of HIT, and proved the high probability of
heparin-induced thrombocytopenia [5]. Consecutive
anti-PF4 antibodies (Enzyme-Linked ImmunoSorbent
Assay HPIA is Heparin Platelet Factor 4-Induced Anti-
bodies [ELISA] Asserachrom HPIA Stago, Asnières
France) were positive (optical density > 2), which con-
firmed the diagnosis of heparin-induced thrombocytope-
nia [6,7].Anticoagulation with LMWH was immediately
stopped and, after initial intravenous lepirudin bolus,
continuous iv. infusion was started and maintained for
an entire week. Thereafter, for five days combined lepir-
udin and warfarin therapy was applied until we reached
the appropriate INR ratio [2]. As a result of this treat-
ment, the patient’s platelet count returned to the preo-
perative level (213 G/l).
A repeat TEE on the 20th post-operative day showed
improved artificial valve motion and less thrombotic
deposition. A control TEE examination (performed 12
weeks after the operation in the outpatient department)
showed a normal artificial valve function with a mean
diastolic mitral gradient of 3.8 mmHg and a complete
resolution of thrombus formation. Figure 5).
Conclusions
We present a case of early post-operative thrombosis of
the prosthetic mitral valve in a patient with heparin-
induced thrombocytopenia. We may remind ourselves
that HIT is one of the most common immune-mediated
adverse drug reactions, with frequencies as high as 2-3%
for certain groups of post-cardiac surgery patients [8,9].
Our case report is a good example that serious compli-
cations of HIT, such as early prosthetic mitral valve
thrombosis, can be successfully managed by means of
the clinical scoring system, with the identification of
heparin platelet factor 4-induced antibodies and the
timely initiation of appropriate drug treatment. We also
emphasise the important role of repeated 2D-TEE
examinations in the early post-operative period of car-
diac surgery patients. Echocardiography also must be
used for follow-up of patients with IE under antibiotic
therapy, along with clinical follow-up. The number,
type, and timing of repeat examinations depend on the
clinical presentation, the type of microorganism, and the
initial echographic findings [10]. Weekly TTE may be
sufficient in non-complicated streptococcal native IE,
while more frequent TEE and TTE controls can be
necessary in postoperative staphylococcal early PVE.
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